Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(3-Chlorophenyl)piperazine dihydrochloride → 1-(3-Chlorophenyl)-4-[2-(isochroman-1-yl)ethyl]piperazine dihydrochloride
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(3-Chlorophenyl)piperazine dihydrochloride | HCID 11957487 | — |
| 반응물 | 1-[2-(Isochroman-1-yl)ethyl]-4-(2-methoxyphenyl)piperazine dihydrochloride monohydrate | HCID 23288951 | — |
| 생성물 | 1-(3-Chlorophenyl)-4-[2-(isochroman-1-yl)ethyl]piperazine dihydrochloride | HCID 23288780 | — |
반응 단계
Following the general procedure of EXAMPLE 1 and making non-critical variations but using 1-(3-chlorophenyl)piperazine dihydrochloride (XI, 0.5169 g (1.92 mmol) in place of 1-(2-chlorophenyl)piperazine dihydrochloride (XI), the title compound is obtained, mp 176.75°-179°; MS (m/z) 356; IR (mineral oil) 2269, 2295, 2166, 2130, 2200 and 1449 cm-1.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05877317 |
| 출처 데이터셋 | uspto-grants-1999_03 |
| ORD ID | ord-2ef37158bc654cd2b5720f88ca6a23ef |
| 출처 메모 | uspto-grants-1999_03 |